| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 3.085 | 36.971 | 63.859 | 74.005 | 75.813 | 87.322 | 104.370 |
| Total Income - EUR | - | - | - | 3.085 | 36.971 | 63.859 | 74.005 | 75.813 | 91.507 | 104.370 |
| Total Expenses - EUR | - | - | - | 1.813 | 35.566 | 56.392 | 48.981 | 67.200 | 90.469 | 90.309 |
| Gross Profit/Loss - EUR | - | - | - | 1.272 | 1.405 | 7.467 | 25.025 | 8.613 | 1.038 | 14.061 |
| Net Profit/Loss - EUR | - | - | - | 1.241 | 1.035 | 6.871 | 24.285 | 7.994 | 169 | 11.913 |
| Employees | - | - | - | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Stefaroma Prod S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 21.655 | 16.585 | 11.537 | 16.402 | 1.222 | 54 |
| Current Assets | - | - | - | 10.932 | 30.419 | 40.321 | 71.537 | 82.387 | 98.067 | 108.592 |
| Inventories | - | - | - | 5.919 | 9.024 | 2.951 | 17.933 | 23.141 | 17.660 | 8.026 |
| Receivables | - | - | - | 4.445 | 20.515 | 36.469 | 33.413 | 51.035 | 55.853 | 64.546 |
| Cash | - | - | - | 568 | 880 | 901 | 20.190 | 8.210 | 24.554 | 36.020 |
| Shareholders Funds | - | - | - | 1.284 | 2.295 | 9.122 | 33.204 | 41.302 | 41.345 | 52.859 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 9.648 | 49.779 | 47.784 | 49.883 | 57.489 | 57.946 | 55.788 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4645 - 4645" | |||||||||
| CAEN Financial Year |
4645
|
|||||||||
Comments - Stefaroma Prod S.r.l.